In Triple Negative Breast Cancer, coupled with MYC, DNMT3a promotes the epithelial to mesenchymal transition and mammosphere formation of TNBC cells by upregulating miR-200b promoter methylation [41]. The gene discussed is MYC; the disease is triple-negative breast carcinoma.